Procurement Summary
Country : USA
Summary : Combined Synopsis/Solicitation for Bio‐Rad CFX Opus 96 Dx (Sole Source)
Deadline : 16 Aug 2024
Other Information
Notice Type : Tender
TOT Ref.No.: 105499094
Document Ref. No. : 75D30124Q78180
Competition : ICB
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : Refer Document
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
Description
This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Federal Acquisition Requirements (FAR) Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; quotes are being requested, and a written solicitation will not be issued.
The solicitation number for this requirement is 75D30124Q78180 and is hereby issued as a Request for Quote (RFQ) using FAR Subpart 13.1 Simplified Acquisition Procedures.
Market research indicates that Bio‐Rad is the the manufacturer and distributor of the CFX Opus 96 Dx to include onsite training and support. As such, CDC shall negotiate a sole source award to Bio‐Rad.
The Centers for Disease Control and Prevention intends to award a firm-fixed-price contract for the following requirement, please either fill in the dollar amounts or provide a separate excel spreadsheet containing the same information including a list of line item number(s) and items, quantities, units of measure, and options, if applicable:
ITEM SUPPLIES / SERVICES QTY / UNIT UNIT PRICE EXTENDED PRICE
0001 Bio‐Rad CFX Opus 96 Dx 1 Each
0002 ENP IQ/OQ CFX Opus 96 1 Each
0003 ddPCR PC COMPUTER 1 Each
Your quote shall include the following:
Total Price for CLIN 0001, 0002 and 0003Delivery Date: 30 days after contract award
Delivery Address: CDC Distribution Center, 3719 N. Peachtree Rd., Chamblee, GA 30341
Acceptance and FOB point
The quote format is at the discretion of the offeror.
It is the offeror's responsibility to be familiar with the applicable clauses and provisions which can be found on the attachment labeled, 75D30124Q78180 _ Clauses and Provisions. Also, all clauses and provisions may be accessed via the Internet at www.acquisition.gov.
This solicitation document and incorporated provisions and clauses are those in effect through the Federal Acquisition Circular (FAC) 20...
Active Contract Opportunity
Notice ID : 75D30124Q78180
Related Notice
Department/Ind. Agency : HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Sub-tier : CENTERS FOR DISEASE CONTROL AND PREVENTION
Office: CDC OFFICE OF ACQUISITION SERVICES
General Information
Contract Opportunity Type: Combined Synopsis/Solicitation (Updated)
All Dates/Times are: (UTC-04:00) EASTERN STANDARD TIME, NEW YORK, USA
Updated Published Date: Aug 08, 2024 05:50 pm EDT
Original Published Date: Aug 08, 2024 05:33 pm EDT
Updated Date Offers Due: Aug 16, 2024 12:00 pm EDT
Original Date Offers Due: Aug 16, 2024 12:00 pm EDT
Inactive Policy: 15 days after date offers due
Updated Inactive Date: Aug 31, 2024
Original Inactive Date: Aug 31, 2024
Initiative: None
Classification
Original Set Aside:
Product Service Code: 6632 - ANALYSIS INSTRUMENTS, MEDICAL LABORATORY USE
NAICS Code: 334516 - Analytical Laboratory Instrument Manufacturing
Place of Performance: Atlanta, GA 30341 USA
Documents
Tender Notice
75D30124Q78180-_Combined-Synopsis_Solicitation.pdf
75D30124Q78180--Clauses-and-Provisions.pdf
75D30124Q78180_SSJ_Redacted.pdf